Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
出版年份 2017 全文链接
标题
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume 24, Issue 8, Pages 1046-1054
出版商
SAGE Publications
发表日期
2017-06-19
DOI
10.1177/1352458517715132
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
- (2016) Lenka Novakova et al. JOURNAL OF NEUROCHEMISTRY
- TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
- (2016) C Alvarez-Gonzalez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Imaging as an Outcome Measure in Multiple Sclerosis
- (2016) Daniel Ontaneda et al. Neurotherapeutics
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
- (2016) Pashtun Shahim et al. Scientific Reports
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
- (2014) J. Romme Christensen et al. NEUROLOGY
- Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
- (2013) J. Kuhle et al. ACTA NEUROLOGICA SCANDINAVICA
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression
- (2013) Sharmilee Gnanapavan et al. PLoS One
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
- (2010) Emma C Tallantyre et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now